| Unique ID issued by UMIN | UMIN000059162 |
|---|---|
| Receipt number | R000066146 |
| Scientific Title | A single-center prospective observational study evaluating the diagnostic yield of endoscopic ultrasound-guided tissue acquisition (EUS-TA) using BD CytoRich Red preservative fluid for pancreatic tumor |
| Date of disclosure of the study information | 2025/09/22 |
| Last modified on | 2025/09/22 21:00:35 |
A study on the effectiveness of a novel preservative fluid (CytoRich Red) for diagnosing pancreatic tumor using endoscopic ultrasound
Pancreatic tumor EUS Study (CytoRich)
A single-center prospective observational study evaluating the diagnostic yield of endoscopic ultrasound-guided tissue acquisition (EUS-TA) using BD CytoRich Red preservative fluid for pancreatic tumor
CytoRich Red EUS-TA Pancreatic Tumor Study
| Japan |
pancreatic tumor
| Hepato-biliary-pancreatic medicine |
Malignancy
YES
To prospectively evaluate the diagnostic yield of endoscopic ultrasound-guided tissue acquisition (EUS-TA) using BD CytoRich Red preservative fluid for pancreatic tumor.
Efficacy
Exploratory
Not applicable
Sensitivity, specificity, and accuracy of rapid on-site evaluation (ROSE)
Diagnostic yield of EUS-TA (Sensitivity, specificity, and accuracy based on histological and final cytological diagnoses)
Technical success rate of EUS-TA procedures
Incidence rate of adverse events (percentage of patients experiencing complications related to EUS-TA), details, and severity of adverse events
Proportion of samples successfully analyzed by next-generation sequencing (NGS) among specimens submitted for analysis
Proportion of tumor cells within collected samples
Detailed genomic alterations identified in successfully analyzed cases
Proportion of patients receiving targeted therapies matched to detected genomic alterations
Comparative evaluation of diagnostic yield and NGS success rate according to the type of needle used
Observational
| 18 | years-old | <= |
| 150 | years-old | >= |
Male and Female
Patients undergoing endoscopic ultrasound-guided tissue acquisition (EUS-TA) for pancreatic tumors at our hospital between April 2025 and March 2028
Patients who provide written informed consent to participate in the study after receiving an adequate explanation and fully understanding the details
Patients who are medically ineligible for EUS-TA
Patients deemed inappropriate for participation in this study by the principal investigator or co-investigators
110
| 1st name | Hidenobu |
| Middle name | |
| Last name | Hara |
Yokohama City Minato Red Cross Hospital
Gastroenterology
2318682
3-12-1 Shinyamashita, Naka-ku, Yokohama, Kanagawa, Japan
0456286100
hidenobu1005_0406@yahoo.co.jp
| 1st name | Hidenobu |
| Middle name | |
| Last name | Hara |
Yokohama City Minato Red Cross Hospital
Gastroenterology
2318682
3-12-1 Shinyamashita, Naka-ku, Yokohama, Kanagawa, Japan
0456286100
hidenobu1005_0406@yahoo.co.jp
Yokohama City Minato Red Cross Hospital
Hidenobu Hara
Self funding
Self funding
Yokohama City Minato Red Cross Hospital
3-12-1 Shinyamashita, Naka-ku, Yokohama, Kanagawa, Japan
0456286100
minato-kenkyu@yokohama.jrc.or.jp
NO
| 2025 | Year | 09 | Month | 22 | Day |
Unpublished
Open public recruiting
| 2025 | Year | 04 | Month | 04 | Day |
| 2025 | Year | 04 | Month | 04 | Day |
| 2025 | Year | 04 | Month | 05 | Day |
| 2028 | Year | 10 | Month | 31 | Day |
Single-center prospective observational study
| 2025 | Year | 09 | Month | 22 | Day |
| 2025 | Year | 09 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066146